does semaglutide cause increased heart rate and the Heart: Focus on Their Love–Hate Relationship Why do weight loss shots

FDA Warning Letters to GLP-1 Peptide Vendors (Sept 2025) In September 2025, the FDA issued more than 50 warning letters to U.S

Other side effects may include injection site reactions, tiredness, dizziness, allergic reactions, hair loss, and gallbladder problems

Aim for Gradual Weight Loss Rapid drops in weight increase the likelihood of telogen effluvium

Organ-Specific Pharmacokinetic Modeling: Small-molecule pharmacokinetics allow tissue exposure mapping across brain, pancreas, liver, adipose, and gastrointestinal compartments

Figure 1 Patients with GSSD, which is classified as mild, moderate, or severe based on clinical symptoms, usually show disease onset symptoms during the neonatal period (5), and approximately 25% of these patients die during the neonatal period owing to infection or electrolyte disturbance ( 2

It is not licensed by the MHRA, is not available on NHS prescription, and has not been appraised by NICE for any indication